{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:44:13Z","timestamp":1792028653176,"version":"4.4.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"15-16","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006202","name":"Fondazione Monte dei Paschi di Siena","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006202","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.cca.2011.04.016","type":"journal-article","created":{"date-parts":[[2011,4,19]],"date-time":"2011-04-19T01:08:46Z","timestamp":1303175326000},"page":"1399-1406","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["F4-neuroprostanes mediate neurological severity in Rett syndrome"],"prefix":"10.1016","volume":"412","author":[{"given":"Cinzia","family":"Signorini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"De Felice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Leoncini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Giardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"D'Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Filosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floriana","family":"Della Ragione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Pecorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Valacchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Ciccoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joussef","family":"Hayek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2011.04.016_bb0005","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.neuron.2007.10.001","article-title":"The story of Rett syndrome: from clinic to neurobiology","volume":"56","author":"Chahrour","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.cca.2011.04.016_bb0010","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/j.1365-2788.2009.01197.x","article-title":"Autism spectrum disorders in genetic syndromes: implications for diagnosis, intervention and understanding the wider autism spectrum disorder population","volume":"53","author":"Moss","year":"2009","journal-title":"J Intellect Disabil Res"},{"key":"10.1016\/j.cca.2011.04.016_bb0015","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/humu.10243","article-title":"Mutations and polymorphisms in the human methyl CpG-binding protein MECP2","volume":"22","author":"Miltenberger-Miltenyi","year":"2003","journal-title":"Hum Mutat"},{"key":"10.1016\/j.cca.2011.04.016_bb0020","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/humu.10194","article-title":"RettBASE: the IRSA MECP2 variation database\u2014a new mutation database in evolution","volume":"21","author":"Christodoulou","year":"2003","journal-title":"Hum Mutat"},{"key":"10.1016\/j.cca.2011.04.016_bb0025","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/ana.22124","article-title":"Rett syndrome: revised diagnostic criteria and nomenclature","volume":"68","author":"Neul","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.cca.2011.04.016_bb0030","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/mrdd.10020","article-title":"Clinical manifestations and stages of Rett syndrome","volume":"8","author":"Hagberg","year":"2002","journal-title":"Ment Retard Dev Disabil Res Rev"},{"key":"10.1016\/j.cca.2011.04.016_bb0035","series-title":"Free radicals in biology and medicine","first-page":"617","article-title":"Free radicals, other reactive species and disease","author":"Halliwell","year":"1999"},{"key":"10.1016\/j.cca.2011.04.016_bb0040","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.freeradbiomed.2009.11.026","article-title":"Oxidative damage in Parkinson disease: measurement using accurate biomarkers","volume":"48","author":"Seet","year":"2010","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.cca.2011.04.016_bb0045","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.freeradbiomed.2009.05.016","article-title":"Systemic oxidative stress in classic Rett syndrome","volume":"47","author":"De Felice","year":"2009","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.cca.2011.04.016_bb0050","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0387-7604(01)00369-2","article-title":"Oxidative stress in Rett syndrome","volume":"23","author":"Sierra","year":"2001","journal-title":"Brain Dev"},{"key":"10.1016\/j.cca.2011.04.016_bb0055","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2174\/092986707780059607","article-title":"Insights into oxidative stress: the isoprostanes","volume":"14","author":"Montuschi","year":"2007","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.cca.2011.04.016_bb0060","doi-asserted-by":"crossref","first-page":"13605","DOI":"10.1074\/jbc.273.22.13605","article-title":"Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid","volume":"273","author":"Roberts","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2011.04.016_bb0065","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.prostaglandins.2005.07.002","article-title":"Nomenclature systems for the neuroprostanes and for the neurofurans","volume":"78","author":"Taber","year":"2005","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.cca.2011.04.016_bb0070","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/humu.20453","article-title":"Italian Rett database and biobank","volume":"28","author":"Sampieri","year":"2007","journal-title":"Hum Mutat"},{"key":"10.1016\/j.cca.2011.04.016_bb0075","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1212\/01.wnl.0000291011.54508.aa","article-title":"Specific mutations in methyl-CpG-binding protein 2 confer different severity in Rett syndrome","volume":"70","author":"Neul","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.cca.2011.04.016_bb0080","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1600-079X.2008.00639.x","article-title":"Free iron, total F2-isoprostanes and total F4-neuroprostanes in a model of neonatal hypoxic\u2013ischemic encephalopathy: neuroprotective effect of melatonin","volume":"46","author":"Signorini","year":"2009","journal-title":"J Pineal Res"},{"key":"10.1016\/j.cca.2011.04.016_bb0085","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/ana.10272","article-title":"Peripheral F2-isoprostanes and F4-neuroprostanes are not increased in Alzheimer's disease","volume":"52","author":"Montine","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/j.cca.2011.04.016_bb0090","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/1531-8249(200005)47:5<670::AID-ANA20>3.0.CO;2-F","article-title":"Influence of mutation type and X chromosome inactivation on Rett syndrome phenotypes","volume":"47","author":"Amir","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1016\/j.cca.2011.04.016_bb0095","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1093\/hmg\/9.7.1119","article-title":"Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: correlation of disease severity with mutation type and location","volume":"9","author":"Cheadle","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cca.2011.04.016_bb0100","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1093\/hmg\/9.9.1369","article-title":"Rett syndrome: analysis of MECP2 and clinical characterization of 31 patients","volume":"9","author":"Huppke","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cca.2011.04.016_bb0105","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/ajmg.a.10053","article-title":"Effects of MECP2 mutation type, location and X-inactivation in modulating Rett syndrome phenotype","volume":"118A","author":"Weaving","year":"2003","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.cca.2011.04.016_bb0110","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1212\/01.wnl.0000304752.50773.ec","article-title":"Investigating genotype\u2013phenotype relationships in Rett syndrome using an international data set","volume":"70","author":"Bebbington","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.cca.2011.04.016_bb0115","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.braindev.2010.01.004","article-title":"Rett syndrome with and without detected MECP2 mutations: an attempt to redefine phenotypes","volume":"33","author":"Temudo","year":"2011","journal-title":"Brain Dev"},{"key":"10.1016\/j.cca.2011.04.016_bb0120","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1136\/jmg.40.5.e52","article-title":"Patients with the R133C mutation: is their phenotype different from patients with Rett syndrome with other mutations?","volume":"40","author":"Leonard","year":"2003","journal-title":"J Med Genet"},{"key":"10.1016\/j.cca.2011.04.016_bb0125","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s003359900157","article-title":"Isolation, physical mapping and northern analysis of the X-linked human gene encoding methyl CpG binding protein, MECP2","volume":"7","author":"D'Esposito","year":"1996","journal-title":"Mamm Genome"},{"key":"10.1016\/j.cca.2011.04.016_bb0130","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1136\/jmg.2006.045260","article-title":"Correlation between clinical severity in patients with Rett syndrome with a p.R168X or p.T158M MECP2 mutation, and the direction and degree of skewing of X-chromosome inactivation","volume":"44","author":"Archer","year":"2007","journal-title":"J Med Genet"},{"key":"10.1016\/j.cca.2011.04.016_bb0135","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3233\/JAD-2009-1126","article-title":"Systemic inflammation and the risk of Alzheimer's disease and dementia: a prospective population-based study","volume":"18","author":"Sundel\u00f6f","year":"2009","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.cca.2011.04.016_bb0140","doi-asserted-by":"crossref","first-page":"e1000667","DOI":"10.1371\/journal.pgen.1000667","article-title":"On the tracks of DNA methylation: an interview to Adrian Bird","volume":"5","author":"Gitschier","year":"2009","journal-title":"PLoS Genet"},{"key":"10.1016\/j.cca.2011.04.016_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.braindev.2008.03.014","article-title":"Plasticity and injury in the developing brain","volume":"31","author":"Johnston","year":"2009","journal-title":"Brain Dev"},{"key":"10.1016\/j.cca.2011.04.016_bb0150","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.clinbiochem.2011.01.007","article-title":"Increased levels of 4HNE-protein plasma adducts in Rett syndrome","volume":"44","author":"Pecorelli","year":"2011","journal-title":"Clin Biochem"},{"key":"10.1016\/j.cca.2011.04.016_bb0155","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.braindev.2008.04.007","article-title":"Diagnostic criteria for the Zappella variant of Rett syndrome (the preserved speech variant)","volume":"31","author":"Renieri","year":"2009","journal-title":"Brain Dev"},{"key":"10.1016\/j.cca.2011.04.016_bb0160","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1093\/hmg\/ddi198","article-title":"CDKL5 belongs to the same molecular pathway of MeCP2 and it is responsible for the early-onset seizure variant of Rett syndrome","volume":"14","author":"Mari","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cca.2011.04.016_bb0165","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.nbd.2010.02.014","article-title":"CDKL5 is a brain MeCP2 target gene regulated by DNA methylation","volume":"38","author":"Carouge","year":"2010","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.cca.2011.04.016_bb0170","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1126\/science.1138389","article-title":"Reversal of neurological defects in a mouse model of Rett syndrome","volume":"315","author":"Guy","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.cca.2011.04.016_bb0175","doi-asserted-by":"crossref","first-page":"10912","DOI":"10.1523\/JNEUROSCI.1869-07.2007","article-title":"Brain-derived neurotrophic factor expression and respiratory function improve after ampakine treatment in a mouse model of Rett syndrome","volume":"27","author":"Ogier","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.cca.2011.04.016_bb0180","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1111\/j.1460-9568.2007.05466.x","article-title":"Treatment with desipramine improves breathing and survival in a mouse model for Rett syndrome","volume":"25","author":"Roux","year":"2007","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.cca.2011.04.016_bb0185","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1073\/pnas.0812394106","article-title":"Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice","volume":"106","author":"Tropea","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cca.2011.04.016_bb0190","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s12975-010-0046-0","article-title":"Docosahexaenoic acid therapy of experimental ischemic stroke","volume":"2","author":"Belayev","year":"2011","journal-title":"Transl Stroke Res"},{"key":"10.1016\/j.cca.2011.04.016_bb0195","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3810\/pgm.2009.11.2083","article-title":"Understanding omega-3 polyunsaturated fatty acids","volume":"121","author":"Calder","year":"2009","journal-title":"Postgrad Med"},{"key":"10.1016\/j.cca.2011.04.016_bb0200","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/BF02536067","article-title":"Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease","volume":"26","author":"Soderberg","year":"1991","journal-title":"Lipids"},{"key":"10.1016\/j.cca.2011.04.016_bb0205","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.4049\/jimmunol.176.3.1848","article-title":"Anti-inflammatory actions of neuroprotectin D1\/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes","volume":"176","author":"Serhan","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.cca.2011.04.016_bb0210","doi-asserted-by":"crossref","unstructured":"Simopoulos AP, in press. Evolutionary aspects of diet: the omega-6\/omega-3 ratio and the brain. Mol Neurobiol. doi:10.1007\/s12035-010-8162-0.","DOI":"10.1007\/s12035-010-8162-0"},{"key":"10.1016\/j.cca.2011.04.016_bb0215","doi-asserted-by":"crossref","unstructured":"Hagiwara H, Nishiyama Y, Katayama Y, in press. Effects of eicosapentaenoic acid on asymmetric dimethylarginine in patients in the chronic phase of cerebral infarction: a preliminary study. J Stroke Cerebrovasc Dis. doi:10.1016\/j.jstrokecerebrovasdis.2010.12.006.","DOI":"10.1016\/j.jstrokecerebrovasdis.2010.12.006"},{"key":"10.1016\/j.cca.2011.04.016_bb0220","doi-asserted-by":"crossref","unstructured":"Lintas C, Sacco R, Persico AM, in press Genome-wide expression studies in Autism spectrum disorder, Rett syndrome, and Down syndrome. Neurobiol Dis. doi:10.1016\/j.nbd.2010.11.010.","DOI":"10.1016\/j.nbd.2010.11.010"},{"key":"10.1016\/j.cca.2011.04.016_bb0225","doi-asserted-by":"crossref","first-page":"6393","DOI":"10.1021\/bi952875+","article-title":"Production of superoxide from hemoglobin-bound oxygen under hypoxic conditions","volume":"35","author":"Balagopalakrishna","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.cca.2011.04.016_bb0230","doi-asserted-by":"crossref","first-page":"7407","DOI":"10.1021\/bi0121048","article-title":"Site-specific cross-linking of human and bovine hemoglobins differentially alters oxygen binding and redox side reactions producing rhombic heme and heme degradation","volume":"41","author":"Nagababu","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.cca.2011.04.016_bb0235","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.bbagen.2004.04.003","article-title":"Iron release, superoxide production and binding of autologous IgG to band 3 dimers in newborn and adult erythrocytes exposed to hypoxia and hypoxia-reoxygenation","volume":"1672","author":"Ciccoli","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.cca.2011.04.016_bb0240","doi-asserted-by":"crossref","first-page":"9383","DOI":"10.1073\/pnas.87.23.9383","article-title":"A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism","volume":"87","author":"Morrow","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cca.2011.04.016_bb0245","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/j.1471-4159.2005.03572.x","article-title":"Secretion of brain-derived neurotrophic factor from PC12 cells in response to oxidative stress requires autocrine dopamine signaling","volume":"96","author":"Wang","year":"2006","journal-title":"J Neurochem"},{"key":"10.1016\/j.cca.2011.04.016_bb0250","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.freeradbiomed.2005.08.023","article-title":"Differential regulation of c-jun and CREB by acrolein and 4-hydroxynonenal","volume":"40","author":"Pugazhenthi","year":"2006","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.cca.2011.04.016_bb0255","doi-asserted-by":"crossref","first-page":"e3669","DOI":"10.1371\/journal.pone.0003669","article-title":"Mecp2-null mice provide new neuronal targets for Rett syndrome","volume":"3","author":"Urdinguio","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2011.04.016_bb0260","first-page":"301","article-title":"Studies on mitochondrial pathogenesis of Rett syndrome: ultrastructural data from skin and muscle biopsies and mutational analysis at mtDNA nucleotides 10463 and 2835","volume":"31","author":"Cardaioli","year":"1999","journal-title":"J Submicrosc Cytol Pathol"},{"key":"10.1016\/j.cca.2011.04.016_bb0265","doi-asserted-by":"crossref","first-page":"5033","DOI":"10.1128\/MCB.01665-05","article-title":"Gene expression analysis exposes mitochondrial abnormalities in a mouse model of Rett syndrome","volume":"26","author":"Kriaucionis","year":"2006","journal-title":"Mol Cell Biol"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898111002105?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898111002105?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T20:00:33Z","timestamp":1762113633000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898111002105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":53,"journal-issue":{"issue":"15-16","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0009898111002105"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2011.04.016","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"F4-neuroprostanes mediate neurological severity in Rett syndrome","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2011.04.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}